Dihydroorotate Dehydrogenase (DHODH) Inhibitors Market Expected to Witness Significant Growth Through 2036, Driven by Expanding Therapeutic Applications Across Autoimmune Diseases, Oncology, and Viral Infections | DelveInsight

Source Summary

The Dihydroorotate Dehydrogenase (DHODH) Inhibitors market is expected to experience robust growth during the forecast period (2022-2036), supported by increasing clinical interest in DHODH-targeted therapies across multiple therapeutic areas, including autoimmune disorders, hematological malignancies, solid tumors, and viral infections. The